Genetic Testing in Men With Metastatic Castration-Resistant Prostate Cancer

IF 22.5 1区医学 Q1 ONCOLOGY

JAMA Oncology Pub Date : 2024-05-02 DOI:10.1001/jamaoncol.2024.0851

Pedro C. Barata, Jonathan Assayag, Benjamin Li, Gordon Siu, Alexander Niyazov

引用次数: 0

Abstract

This cross-sectional study assesses homologous recombination repair mutation genetic testing and associated characteristics among men with metastatic castration-resistant prostate cancer (mCRPC).

查看原文本刊更多论文

转移性抗性前列腺癌男性患者的基因检测

这项横断面研究评估了同源重组修复突变基因检测和转移性抗性前列腺癌（mCRPC）男性患者的相关特征。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

JAMA Oncology Medicine-Oncology

自引率

1.80%

发文量

423

期刊介绍： JAMA Oncology is an international peer-reviewed journal that serves as the leading publication for scientists, clinicians, and trainees working in the field of oncology. It is part of the JAMA Network, a collection of peer-reviewed medical and specialty publications.